General Principles for the Validation of Proarrhythmia Risk Prediction Models: An Extension of the CiPA In Silico Strategy.
Li, Zhihua *,1; Mirams, Gary R. 2; Yoshinaga, Takashi 3; Ridder, Bradley J. 1; Han, Xiaomei 1; Chen, Janell E. 4; Stockbridge, Norman L. 5; Wisialowski, Todd A. 6; Damiano, Bruce 7; Severi, Stefano 8; Morissette, Pierre 9; Kowey, Peter R. 10; Holbrook, Mark 11; Smith, Godfrey 12,13; Rasmusson, Randall L. 14; Liu, Michael 15; Song, Zhen 15; Qu, Zhilin 15; Leishman, Derek J. 16; Steidl-Nichols, Jill 17; Rodriguez, Blanca 18; Bueno-Orovio, Alfonso 19; Zhou, Xin 20; Passini, Elisa 18; Edwards, Andrew G. 19; Morotti, Stefano 19; Ni, Haibo 19; Grandi, Eleonora 19; Clancy, Colleen E. 19; Vandenberg, Jamie 20,21; Hill, Adam 20,21; Nakamura, Mikiko 22; Singer, Thomas 23; Polonchuk, Liudmila 23; Greiter-Wilke, Andrea 23; Wang, Ken 23; Nave, Stephane 24; Fullerton, Aaron 25; Sobie, Eric A. 26; Paci, Michelangelo 27; Musuamba Tshinanu, Flora 28,29; Strauss, David G. 1
[Article]
Clinical Pharmacology & Therapeutics.
107(1):102-111, January 2020.
(Format: HTML, PDF)